Valeant Pharmaceuticals International Investor Relations Salaries in Boulder | Comparably
Valeant Pharmaceuticals International develops and markets medications used in the fields of neurology, dermatology and infectious diseases. read more
EMPLOYEE
PARTICIPANTS
8
TOTAL
RATINGS
107

Valeant Pharmaceuticals International Investor Relations Salaries in Boulder

The average Valeant Pharmaceuticals International Investor Relations in Boulder earns an estimated $59,992 annually. Valeant Pharmaceuticals International's Investor Relations compensation is $21,939 less than the US average for a Investor Relations.

In Boulder, The Communications Department at Valeant Pharmaceuticals International earns $9,775 more on average than the Enterprise Risk Department.

Last updated 2 years ago.

$35k
$47k
$63k
$70k
$109k
$139k
$168k
$59,992
Average Compensation
$59,992
avg. base

Investor Relations Salaries at Valeant Pharmaceuticals International

* estimated salary

Compensation at Valeant Pharmaceuticals International by Department

In Boulder, The Communications Department averages $9,775 more than the Enterprise Risk Department.

Communications
$192,901 Avg. total comp.
Enterprise Risk
$183,126 Avg. total comp.
-$10k
Product
$151,572 Avg. total comp.
-$41k

Investor Relations Compensation by Gender (All Companies)

The average female Investor Relations at companies similar size to Valeant Pharmaceuticals International reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.

How Investor Relations at Valeant Pharmaceuticals International Rate Their Compensation

The majority of Investor Relations at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Investor Relations at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International

×
Rate your company